Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro

Latency-reversing agents (LRAs) are considered a potential tool to cure human immunodeficiency virus type 1 (HIV-1) infection, but when they are taken alone, virus production by reactivated cells and subsequent infection will occur. Hence, it is crucial to simultaneously take appropriate measures to...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Microbiol
Asıl Yazarlar: Hattori, Shin-ichiro, Matsuda, Kouki, Tsuchiya, Kiyoto, Gatanaga, Hiroyuki, Oka, Shinichi, Yoshimura, Kazuhisa, Mitsuya, Hiroaki, Maeda, Kenji
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2018
Konular:
Microbiology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6156138/
https://ncbi.nlm.nih.gov/pubmed/30283406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2018.02022
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller